Status:
UNKNOWN
Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination
Lead Sponsor:
Eastern Virginia Medical School
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Papillomavirus Vaccines
Eligibility:
All Genders
27-69 years
Phase:
PHASE4
Brief Summary
Currently there are no standards for healthcare worker vaccination with the HPV, Gardasil-9 vaccine. For health care workers, the CDC only recommends for vaccination against hepatitis B, influenza vir...
Detailed Description
Initial antibody titers will be measured immediately prior to initial vaccination (month 0). This will entail a blood-draw sample (less than 1 teaspoon) that will be sent to FOCUS labs for evaluation....
Eligibility Criteria
Inclusion
- • Actively practicing attending surgeon in the field of Otolaryngology, General Surgery, Urology, or Obstetrics-Gynecology employed by EVMS or credentialed by CHKD and/or SNGH.
- or
- • Current residents of EVMS Otolaryngology, General Surgery, Urology, or Obstetrics-Gynecology programs
Exclusion
- • Age 26 or younger
- Age over 69
- Hypersensitivity to vaccine component
- History of severe allergic or hypersensitivity reactions to yeast
- History of previous HPV vaccination with 9 valent vaccine
- Pregnant
- Moderate or severe acute illness
Key Trial Info
Start Date :
April 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03350698
Start Date
April 6 2018
End Date
December 30 2023
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
EVMS Otolaryngology
Norfolk, Virginia, United States, 23507